Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Reexamination Certificate
2006-08-08
2006-08-08
Yoon, Tae H. (Department: 1714)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
C424S499000, C523S200000, C524S504000, C524S505000, C524S845000, C528S271000
Reexamination Certificate
active
07087244
ABSTRACT:
Disclosed is a thermogelling biodegradable aqueous polymer solution useful in providing a bioactive agent delivery system. A thermogelling biodegradable aqueous polymer solution may comprise a biocompatible block and a biodegradable polypeptide block, where the blocks are linked to form a polymer of a general structure comprising the formula of CnDm, wherein n is equal to or greater than 1, m is equal to or greater than 1, C is a biodegradable polypeptide block, and D is a biocompatible soluble polymer having a chain length such that if D is not biodegradable, D may be eliminated through a glomeruli filtration system.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4438253 (1984-03-01), Casey et al.
patent: 4526938 (1985-07-01), Churchill et al.
patent: 4904584 (1990-02-01), Shaw
patent: 4942035 (1990-07-01), Churchill et al.
patent: 4946686 (1990-08-01), McClelland et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5278201 (1994-01-01), Dunn et al.
patent: 5449513 (1995-09-01), Yokoyama et al.
patent: 5462990 (1995-10-01), Hubbell et al.
patent: 5575815 (1996-11-01), Slepian et al.
patent: 5634946 (1997-06-01), Slepian
patent: 5646131 (1997-07-01), Badwan et al.
patent: 5662609 (1997-09-01), Slepian
patent: 5674287 (1997-10-01), Slepian et al.
patent: 5702717 (1997-12-01), Cha et al.
patent: 5749915 (1998-05-01), Slepian
patent: 5749922 (1998-05-01), Slepian et al.
patent: 5843156 (1998-12-01), Slepian et al.
patent: 5858746 (1999-01-01), Hubbell et al.
patent: 6004573 (1999-12-01), Rathi et al.
patent: 6007845 (1999-12-01), Domb et al.
patent: 6060582 (2000-05-01), Hubbell et al.
patent: 6083486 (2000-07-01), Weissleder et al.
patent: 6083524 (2000-07-01), Sawhney et al.
patent: 6117949 (2000-09-01), Rathi et al.
patent: 6290729 (2001-09-01), Slepian et al.
patent: 6352682 (2002-03-01), Leavitt et al.
patent: 6443941 (2002-09-01), Slepian et al.
patent: 2001/0034050 (2001-10-01), Chilkoti
patent: 2002/0032309 (2002-03-01), Deming et al.
patent: 2002/0131935 (2002-09-01), Fisher et al.
patent: 2002/0168319 (2002-11-01), Filler et al.
patent: 2004/0228794 (2004-11-01), Weller et al.
patent: WO 95/00162 (1995-01-01), None
patent: WO 9603112 (1996-02-01), None
patent: WO 98/55147 (1998-12-01), None
patent: WO 99/07343 (1999-02-01), None
patent: WO 99/18142 (1999-04-01), None
patent: WO99/55386 (1999-11-01), None
patent: WO 00/21574 (2000-04-01), None
patent: WO 00/56774 (2000-09-01), None
patent: WO 01/67104 (2001-09-01), None
patent: WO 02/26215 (2002-04-01), None
patent: WO03/087196 (2003-10-01), None
Deming, Timothy J., “Facile synthesis of block copolypeptides of defined architecture,”Nature, vol. 390, pp. 386-390 (Nov. 1997).
Behravesh, E. et al., “Synthesis and Characterization of Triblock Copolyers of Methoxy Poly(ethylene glycol) and propylene fumarate),”pp. A-F (2001).
Alexandridis, P. et al., “Micellization of Poly(ethykene oxide)-Poly(propylene oxide)-Poly(ethylene oxide) Triblock Copolymers in Aqueous Solutions. Thermodynamics of Copolymer Association,” pp. 2414-2425 (1994).
Bellare, JR. et al., “Controlled Enviroment Vitrification System: An Improved Sample Preparation Technique,” pp. 87-111 (1988).
Betre, H. et al., “Injectable Elastin-Like Polypeptide for Cartilage Repair,” 47thAnnual Meeting, Orthopaedic Research Society, p. 601 (Feb. 25-28, 2001).
Brown, W. et al., “Micelle and Gel Formation in a Poly(ethylene oxide)/Poly(propylene oxide)/Poly(ethylene oxide) Triblock Copolymer in Water Solution. Dynamic and Static Light Scattering and Oscillatory Sheer Measurements,” pp. 1850-1858 (1991).
Cau, Fl et al., “H NMR Relaxation Studies of the Micellization of a Poly(ethylene oxide)-Poly(propylene oxide)-Poly(propylene oxide)-Poly(ethylene oxide) Triblock Copolymer in Aqueous Solution,” pp. 170-178 (1996).
Chen, G. et al., “Graft Copolymers that Exhibit Temperature-Induced Phase Transitions Over a Wide Range of pH,” pp. 49-52 (1995).
Deng, Y. et al., “Thermodynamics of Micellisation and gelation of Oxyethylene/Oxypropylene Diblock Copolymers in Aqueous Solution Studied by Light Scattering and Differential Scanning Calorimetry,” pp. 1441-1446 (1992).
Discher, BM. et al., “Polymersomes: Tough Vesicles Made From Diblock Copolymers,” pp. 1-9 (1999).
Feil, H. et al., “Effects of Comonomer Hydrophilicity and Ionization on the Lower Critical Solution Temperature of N-Isopropylacrylamide Copolymers,” pp. 2496-2500 (1993).
Gutowska, A. et al., “Injectable Gels for Tissue Engineering,” pp. 1-26 (2000).
Hill-West, JL. et al., “Inhibition of Thrombosis and Intimal Thickening byin situPhotopolymerization of Thin Hydrogel Barriers,” pp. 5967-5671 (1994).
Israelachvili, JN., “Intermolecular and Surface Forces,” pp. 102-106 & 207-208 (1985).
Jeong, B. et al., “Biodegradable Block Copolymers as Injectable Drug-Delivery Systems,” pp. 860-862 (1997).
Jeong, B. et al., “Diodegradable Thermoreversible Gelling Polymer with a Maximum Modulus at Body Temperature,” pp. 1-13 (2000).
Jeong, B. et al., “Biodegradable Thermosensitive Micelles of PEG-PLGA-PEG Triblock Copolymers,” pp. 185-193 (1999).
Jeong, B. et al., “Drug Release from Biodegradable Injectable Thermosensitive Hydrogel of PEG-PLGA-PEG Triblock Copolymers,” pp. 155-163 (2000).
Jeong, B. et al., “In situGelation of PEG-PLGA-PEG Triblock Copolymer Aqueous Solutions and Degradation Thereof,” pp. 171-177 (2000).
Jeong, B. et al., “New Biodegradable Polymers for Injectable Drug Delivery Systems,” pp. 109-114 (1999).
Jeong, B. et al., “Reverse Thermogelling Biodegradable Polymers: PEG-g-PLGA,” pp. 1-6.
Jeong, B. et al., “Thermogelling Biodegradable Polymers with Hydrophilic Backbones: PEG-g-PLGA,” pp. A-F (2000).
Jeong, B. et al., “Thermoreversible Gelation of PEG-PLGA-PEG Triblock Copolymer Aqueous Solutions,” pp. 7064-7069 (1999).
Jeong, B. et al., “Thermoreversible Gelatin of Poly(Ethylene Oxide) Biodegradable Polyester Block Copolymers,” pp. 751-760 (1998).
Jhon, MS. et al., “Water and Hydrogels,” pp. 509-522 (1973).
Johnston, TP. et al., “Sustained Delivery of Interleukin-2 From a Polymer 407 Gel Matrix Following Intraperitoneal Injection of Mice,” pp. 425-434 (1992).
Malmsten, M. et al., “Self-Assembly in Aqueous Block Copolymer Solutions,” pp. 5440-5445 (1992).
Meyer, DE. et al., “Drug Targeting Using Thermally Responsive Polymers and Local Hyperthermia,”Journal of Controlled Release, vol. 71, pp. 213-224 (2001).
Moiseev, L., “Temperature-Dependent Properties of Elastin-like Polypeptides (ELP),” http://www.bu.edu/mcbb/calendar—of—events/abstracts/moiseev—abstract.htm, (Jan. 21, 2000).
Nath, N. et al., “Interfacial Phase Transition of an Environmentally Responsive Elastin Biopolymer Adsorbed on Functionalized Gold Nanoparticles Studied by Colloidal Surface Plasmon Resonance,”J. Am. Chem. Soc., vol. 123, pp. 8197-8202 (2001).
Odian, G., “Principles of Polymerization,” pp. 512-515 (1981).
Raucher, D. et al., “Enhanced Uptake of a Thermally Responsive Polypeptide by Tumor Cells in Responsive to its Hyperthermia-mediated Phase Transition,”Cancer Research, vol. 61, pp. 7163-7170 (Oct. 1, 2001).
Rosiak, JM. et al., “Hydrogels for Biomedical.Purposes,” pp. 335-339 (1995).
Stile, RA. et al., “Synthesis and Characterization of Injectable Poly(N-isopropylacrylamide)-Based Hydrogels that Support Tissue Formationin Vitro,” pp. 7370-7379 (1999).
Tanodekaew, S. et al., “Gelation of Aqueous Solutions of Diblock Copolymers of Ethylene Oxide andD.L-Lactide,” pp. 3385-3395 (1997).
Thomas, JL. et al., “Tuning the Response of a pH-Sensitive Membrane Switch,” pp. 2949-2950 (1995).
Wanka, G. et al., “T
Gutowska Anna
Jeong Byeongmoon
Battelle (Memorial Institute)
Klarquist & Sparkman, LLP
Yoon Tae H.
LandOfFree
Thermogelling oligopeptide polymers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thermogelling oligopeptide polymers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thermogelling oligopeptide polymers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3653734